{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T13:01:32Z","timestamp":1648990892166},"reference-count":64,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.neurol.2010.07.015","type":"journal-article","created":{"date-parts":[[2010,9,2]],"date-time":"2010-09-02T08:40:27Z","timestamp":1283416827000},"page":"793-799","source":"Crossref","is-referenced-by-count":1,"title":["Comment prendre en charge la somnolence associ\u00e9e \u00e0 la maladie de Parkinson\u00a0?"],"prefix":"10.1016","volume":"166","author":[{"given":"V.","family":"Cochen De Cock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Dauvilliers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2010.07.015_bib0005","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1212\/01.wnl.0000183056.89590.0d","article-title":"Excessive daytime sleepiness and subsequent development of Parkinson disease","volume":"65","author":"Abbott","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2010.07.015_bib0010","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1046\/j.1365-2869.2000.00171.x","article-title":"Effect of low and high frequency thalamic stimulation on sleep in patients with Parkinson's disease and essential tremor","volume":"9","author":"Arnulf","year":"2000","journal-title":"J Sleep Res"},{"key":"10.1016\/j.neurol.2010.07.015_bib0015","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1212\/WNL.58.7.1019","article-title":"Parkinson's disease and sleepiness: an integral part of PD","volume":"58","author":"Arnulf","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2010.07.015_bib0020","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/S1353-8020(09)70792-8","article-title":"Sleepiness in Parkinson's disease","volume":"15","author":"Arnulf","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2010.07.015_bib0025","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1001\/archneur.62.8.1242","article-title":"Sudden uncontrollable somnolence and medication use in Parkinson disease","volume":"62","author":"Avorn","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2010.07.015_bib0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/brain\/awm220","article-title":"Parkinson's disease, sleepiness and hypocretin\/orexin","volume":"131","author":"Baumann","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2010.07.015_bib0035","doi-asserted-by":"crossref","first-page":"958","DOI":"10.4088\/JCP.v67n0613","article-title":"Mood and sleep in Parkinson's disease","volume":"67","author":"Borek","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.neurol.2010.07.015_bib0040","doi-asserted-by":"crossref","first-page":"S101","DOI":"10.1016\/S1353-8020(09)70845-4","article-title":"Dopamine receptor agonists and sleep disturbances in Parkinson's disease","volume":"15","author":"Chaudhuri","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.neurol.2010.07.015_bib0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.expneurol.2008.12.005","article-title":"The dopaminergic basis of sleep dysfunction and nonmotor symptoms of Parkinson's disease: evidence from functional imaging","volume":"16","author":"Chaudhuri","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.neurol.2010.07.015_bib0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.sleep.2009.05.008","article-title":"Is obstructive sleep apnea a problem in Parkinson's disease?","volume":"11","author":"Cochen De Cock","year":"2010","journal-title":"Sleep Med"},{"key":"10.1016\/j.neurol.2010.07.015_bib0055","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1093\/brain\/awp263","article-title":"Cerebrospinal hypocretin, daytime sleepiness and sleep architecture in Parkinson's disease dementia","volume":"132","author":"Compta","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2010.07.015_bib0060","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/jnnp.74.12.1667","article-title":"CSF hypocretin-1\u00a0levels in narcolepsy. Kleine-Levin syndrome, and other hypersomnias and neurological conditions","volume":"74","author":"Dauvilliers","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2010.07.015_bib0065","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/jnnp.2006.100016","article-title":"Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's disease","volume":"78","author":"Devos","year":"2007","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2010.07.015_bib0070","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/archneur.1992.00530270125028","article-title":"An estimate of the incidence of depression in idiopathic Parkinson's disease","volume":"49","author":"Dooneief","year":"1992","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2010.07.015_bib0075","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/mds.870050404","article-title":"Sleep disorders and sleep effect in Parkinson's disease","volume":"5","author":"Factor","year":"1990","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2010.07.015_bib0080","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1212\/WNL.58.3.460","article-title":"Effect of ropinirole on sleep onset: a randomized, placebo-controlled study in healthy volunteers","volume":"58","author":"Ferreira","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2010.07.015_bib0085","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/brain\/awm090","article-title":"Hypocretin (orexin) loss in Parkinson's disease","volume":"130","author":"Fronczek","year":"2007","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.neurol.2010.07.015_bib0090","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1212\/WNL.52.9.1908","article-title":"Falling asleep at the wheel: motor vehicle mishaps in persons taking pramipexole and ropinirole","volume":"52","author":"Frucht","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2010.07.015_bib0095","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/WNF.0b013e3181a946d5","article-title":"Sleep attack associated to rotigotine","volume":"32","author":"Garcia Ruiz","year":"2009","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.neurol.2010.07.015_bib0100","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/mds.21541","article-title":"A nationwide survey of excessive daytime sleepiness in Parkinson's disease in France","volume":"22","author":"Ghorayeb","year":"2007","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2010.07.015_bib0105","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.287.4.455","article-title":"Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group","volume":"287","author":"Hobson","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.neurol.2010.07.015_bib0110","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1038\/sj.npp.1300250","article-title":"The effect of cabergoline on sleep, periodic leg movements in sleep, and early morning motor function in patients with Parkinson's disease","volume":"28","author":"Hogl","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neurol.2010.07.015_bib0115","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/jnnp.72.5.661","article-title":"Sleep symptoms and polysomnographic architecture in advanced Parkinson's disease after chronic bilateral subthalamic stimulation","volume":"72","author":"Iranzo","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2010.07.015_bib0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/BF03159935","article-title":"Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway","volume":"14","author":"Jellinger","year":"1991","journal-title":"Mol Chem Neuropathol"},{"key":"10.1016\/j.neurol.2010.07.015_bib0125","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1468-1331.2004.00971.x","article-title":"Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment","volume":"12","author":"Kaynak","year":"2005","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2010.07.015_bib0130","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/S0022-5347(05)00324-1","article-title":"Brain activation during detrusor overactivity in patients with Parkinson's disease: a positron emission tomography study","volume":"175","author":"Kitta","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.neurol.2010.07.015_bib0135","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1002\/mds.20163","article-title":"Predictors of sudden onset of sleep in Parkinson's disease","volume":"19","author":"Korner","year":"2004","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2010.07.015_bib0140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/mds.10307","article-title":"Restless legs syndrome in Parkinson's disease: a case-controlled study","volume":"18","author":"Krishnan","year":"2003","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2010.07.015_bib0145","first-page":"329","article-title":"Sleep disorders in Parkinson's disease","volume":"91","author":"Larsen","year":"2003","journal-title":"Adv Neurol"},{"key":"10.1016\/j.neurol.2010.07.015_bib0150","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/00002826-198812000-00004","article-title":"The nighttime problems of Parkinson's disease","volume":"11","author":"Lees","year":"1988","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.neurol.2010.07.015_bib0155","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.nbd.2007.12.003","article-title":"An inverse agonist of the histamine H(3) receptor improves wakefulness in narcolepsy: studies in orexin-\/- mice and patients","volume":"30","author":"Lin","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neurol.2010.07.015_bib0160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0072-9752(07)83012-0","article-title":"Scales to measure parkinsonism","volume":"83","author":"Martinez-Martin","year":"2007","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.neurol.2010.07.015_bib0165","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2125.2008.03310.x","article-title":"Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-Dopa, bromocriptine and pramipexole in healthy subjects","volume":"67","author":"Micallef","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.neurol.2010.07.015_bib0170","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00415-004-0305-7","article-title":"Effects of bilateral subthalamic stimulation on sleep in Parkinson's disease","volume":"251","author":"Monaca","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2010.07.015_bib0175","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.sleep.2005.12.002","article-title":"Vigilance troubles in Parkinson's disease: a subjective and objective polysomnographic study","volume":"7","author":"Monaca","year":"2006","journal-title":"Sleep Med"},{"key":"10.1016\/j.neurol.2010.07.015_bib0180","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mds.22760","article-title":"Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study","volume":"25","author":"Negre-Pages","year":"2010","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2010.07.015_bib0185","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/mds.20734","article-title":"Prevalence and clinical characteristics of restless legs syndrome in Japanese patients with Parkinson's disease","volume":"21","author":"Nomura","year":"2006","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2010.07.015_bib0190","first-page":"382","article-title":"The causes of abnormal pulmonary function in Parkinson's disease","volume":"105","author":"Obenour","year":"1972","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.neurol.2010.07.015_bib0195","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0022-3999(02)00443-9","article-title":"Prevalence of restless legs syndrome and periodic limb movement disorder in the general population","volume":"53","author":"Ohayon","year":"2002","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.neurol.2010.07.015_bib0320","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/archneur.59.3.421","article-title":"Exploring the relationship between Parkinson disease and restless legs syndrome","volume":"59","author":"Ondo","year":"2002","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2010.07.015_bib0200","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1136\/jnnp.2005.065870","article-title":"Modafinil for daytime somnolence in Parkinson's disease: double-blind, placebo controlled parallel trial","author":"Ondo","year":"2005","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2010.07.015_bib0205","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1001\/archneur.65.10.1337","article-title":"Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study","volume":"65","author":"Ondo","year":"2008","journal-title":"Arch Neurol"},{"issue":"58","key":"10.1016\/j.neurol.2010.07.015_bib0210","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1212\/WNL.58.3.498","article-title":"Normal hypocretin-1\u00a0levels in Parkinson's disease patients with excessive daytime sleepiness","volume":"12","author":"Overeem","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2010.07.015_bib0215","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ncpneuro0632","article-title":"Rotigotine skin patch for the treatment of fluctuating Parkinson's disease\u00a0\u2013\u00a0how does it compare with pramipexole?","volume":"3","author":"Pahwa","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"issue":"4\u00a0Suppl. 1","key":"10.1016\/j.neurol.2010.07.015_bib0220","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/BF03160564","article-title":"Sleep disorder related to Parkinson's disease","volume":"244","author":"Partinen","year":"1997","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2010.07.015_bib0225","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/mds.22694","article-title":"Restless legs syndrome in Parkinson's disease","volume":"24","author":"Peralta","year":"2009","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2010.07.015_bib0230","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000276402","article-title":"Excessive daytime sleepiness in Parkinson's disease: characteristics and determinants","volume":"63","author":"Poryazova","year":"2010","journal-title":"Eur Neurol"},{"key":"10.1016\/j.neurol.2010.07.015_bib0235","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/archneur.1994.00540210094018","article-title":"Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring","volume":"51","author":"van Hilten","year":"1994","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2010.07.015_bib0240","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1001\/archneur.61.1.97","article-title":"Predictors of impaired daytime sleep and wakefulnes in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists","volume":"60","author":"Razmy","year":"2004","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2010.07.015_bib0245","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1176\/jnp.8.4.383","article-title":"Anxiety and Parkinson's disease","volume":"8","author":"Richard","year":"1996","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.neurol.2010.07.015_bib0250","first-page":"108","article-title":"Daytime sleepiness and the COMT val158met polymorphism in patients with Parkinson disease","volume":"29","author":"Rissling","year":"2006","journal-title":"Sleep"},{"key":"10.1016\/j.neurol.2010.07.015_bib0255","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1389-9457(03)00058-3","article-title":"Assessment of sleepiness and unintended sleep in Parkinson's disease patients taking dopamine agonists","volume":"4","author":"Roth","year":"2003","journal-title":"Sleep Med"},{"key":"10.1016\/j.neurol.2010.07.015_bib0260","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1365-2869.2000.00201.x","article-title":"Fast track: daytime sleepiness in Parkinson's disease","volume":"9","author":"Rye","year":"2000","journal-title":"J Sleep Res"},{"key":"10.1016\/j.neurol.2010.07.015_bib0265","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/sleep\/15.3.226","article-title":"Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder","volume":"15","author":"Schenck","year":"1992","journal-title":"Sleep"},{"key":"10.1016\/j.neurol.2010.07.015_bib0270","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1093\/sleep\/27.5.967","article-title":"Daytime sleepiness and alertness in patients with Parkinson disease","volume":"27","author":"Stevens","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.neurol.2010.07.015_bib0275","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/mds.870100318","article-title":"Beneficial effect of intranasal desmopressin for nocturnal polyuria in Parkinson's disease","volume":"10","author":"Suchowersky","year":"1995","journal-title":"Mov Disord"},{"key":"10.1016\/j.neurol.2010.07.015_bib0280","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1212\/WNL.58.3.465","article-title":"Evaluation of somnolence in Parkinson's disease: comparison with age- and sex-matched controls","volume":"58","author":"Tan","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2010.07.015_bib0285","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/archneur.1996.00550020087019","article-title":"The occurrence of depression in Parkinson's disease. A community-based study","volume":"53","author":"Tandberg","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2010.07.015_bib0290","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1093\/brain\/awm097","article-title":"Hypocretin (orexin) cell loss in Parkinson's disease","volume":"130","author":"Thannickal","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2010.07.015_bib0295","first-page":"92","article-title":"Ropinirole in the treatment of restless legs syndrome: results from the Treat RLS 1\u00a0study, a 12week, randomised-, placebo-controlled study in 10\u00a0European countries","volume":"75","author":"Trenkwalder","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2010.07.015_bib0300","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1378\/chest.96.1.210","article-title":"Reversibility of upper airway obstruction after levodopa therapy in Parkinson's disease","volume":"96","author":"Vincken","year":"1989","journal-title":"Chest"},{"key":"10.1016\/j.neurol.2010.07.015_bib0305","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/sleep\/27.2.317","article-title":"Serotonergic antidepressants are associated with REM sleep without atonia","volume":"27","author":"Winkelman","year":"2004","journal-title":"Sleep"},{"key":"10.1016\/j.neurol.2010.07.015_bib0310","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.sleep.2003.07.005","article-title":"Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS)","volume":"5","author":"Winkelman","year":"2004","journal-title":"Sleep Med"},{"key":"10.1016\/j.neurol.2010.07.015_bib0315","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jns.2006.08.004","article-title":"CSF orexin levels of Parkinson's disease, dementia with Lewy bodies, progressive supranuclear palsy and corticobasal degeneration","volume":"250","author":"Yasui","year":"2006","journal-title":"J Neurol Sci"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378710003413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378710003413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T09:51:53Z","timestamp":1544262713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378710003413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":64,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0035378710003413"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2010.07.015","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}